生物
祖细胞
CDX2
癌症研究
SOX2
转录组
人口
转录因子
细胞生物学
祖细胞
干细胞
胃粘膜
发育不良
硫氧化物9
细胞分化
PDX1型
起源细胞
核糖核酸
电池类型
慢性胃炎
细胞
长非编码RNA
单细胞分析
免疫学
体细胞
基因表达谱
作者
Mi Lin,Qi‐Yue Chen,Guang‐Tan Lin,Shanqiang Zhou,Xingliang Xiong,Ru‐Hong Tu,方银善,Tala FNU,Sanny S.W. Chung,Shu-Zhen Xu,Meichen Jiang,Xiao-Bo Huang,Qing Zhong,Chang‐Ming Huang,Dean Y. Maeda,John A. Zebala,Ping Li,Jian‐Xian Lin,Jianwen Que
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2026-10-22
标识
DOI:10.1158/0008-5472.can-25-5714
摘要
Gastric mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) are aggressive malignancies that exhibit complex cellular heterogeneity driven by the dual lineages. The dismal patient survival rates highlight the need to elucidate the cellular origin of gastric MiNENs and the key regulatory mechanisms to develop improved treatment strategies. Here, we identified a gastric POU2F3+epithelial population as a potential cell of origin for gastric MiNENs. Lineage tracing and single-cell RNA sequencing further identified that POU2F3+ cells include three distinct subpopulations with divergent differentiation trajectories: progenitor cells (SOX2+SOX9+), tuft cells (POU2F3+DCLK1+), and neuroendocrine cells (SYP+CHGA+). Combined Rb1/Trp53 deletion and MYC overexpression in POU2F3+ epithelial cells (Pou2f3-CreERT; Rb1fl/fl; Trp53fl/fl; LSL-MycT58A) led to the rapid development of gastric MiNENs containing both neuroendocrine and non-neuroendocrine lesions, recapitulating human gastric MiNENs pathology. Transcription factor activity analysis and spatial transcriptomics revealed SOX2 and SOX9 as critical regulators driving subpopulation specification, with SOX2 and SOX9 being enriched in dysplasia and adenocarcinoma, respectively. Bulk RNA sequencing further showed increased expression of CXCL5 in gastric MiNENs, and inhibition of CXCL5 reduced the growth of tumor organoids and xenografts in mouse models. Together these findings offer a physiologically relevant model for studying gastric MiNENs and identify CXCL5 as a potential therapeutic target for this heterogeneous cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI